US President Donald Trump on Monday designated Afghanistan as one of five countries that have “failed demonstrably” to meet international drug control commitments, citing Taliban involvement in the narcotics trade and the expansion of methamphetamine production.
In a determination sent to Congress and released by the State Department, Trump identified 23 nations as either major drug-producing or transit countries, including Afghanistan, Mexico, China, India, Pakistan, and several Latin American and Caribbean states. The designation, the White House stressed, does not necessarily reflect the level of cooperation by each government, but rather geographic and economic factors that facilitate drug production or trafficking.
However, Afghanistan, along with Bolivia, Burma, Colombia and Venezuela, was singled out for failing to adhere to international counternarcotics obligations over the past year. “Despite the Taliban’s announced ban on illegal drugs, stockpiles and production — including methamphetamine — continue to flow into international markets,” Trump wrote. “Some members of the Taliban continue to profit from this trade, and I once again designate Afghanistan as having failed demonstrably to uphold its drug control obligations.”
The determination links narcotics revenues in Afghanistan to the financing of transnational criminal networks and international terrorists. The United Nations Office on Drugs and Crime has repeatedly described Afghanistan as a leading producer of opium and heroin, estimating earlier this year that opiate trafficking from Afghanistan generates nearly $10 billion annually, much of it through Central Asia to Russia.
The designation follows years of US accusations that the Taliban benefit financially from the drug economy. While Taliban authorities have promoted their 2022 ban on poppy cultivation as a counternarcotics success, UN reports suggest production and trafficking continue, particularly with synthetic drugs such as methamphetamine.
Afghanistan’s inclusion on the list means US assistance could be restricted, though Trump’s determination also notes that in some cases aid is exempted if deemed vital to US national interests.
Trump’s statement also highlighted the fentanyl crisis in the United States, with more than 200 daily deaths linked to illicit drugs in 2024, framing the global narcotics fight as a core national security priority.
